Insiders · EVMN

EVMN insider transactions

Evommune Inc. (EVMN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for EVMN

• 8d
  SEC Form 4 filed by Patel Jeegar Pravinkumar

  4 - Evommune, Inc. (0002044725) (Issuer)
• 8d
  SEC Form 4 filed by Drew Janice Suzann

  4 - Evommune, Inc. (0002044725) (Issuer)
• 8d
  SEC Form 4 filed by Bauer Eugene

  4 - Evommune, Inc. (0002044725) (Issuer)
• 8d
  SEC Form 4 filed by Carver Kyle

  4 - Evommune, Inc. (0002044725) (Issuer)
• 8d
  SEC Form 4 filed by Moss Gregory S.

  4 - Evommune, Inc. (0002044725) (Issuer)
• 8d
  SEC Form 4 filed by Pena Luis C.

  4 - Evommune, Inc. (0002044725) (Issuer)
• 65d
  Director Lsp 7 Cooperative Ua was granted 358,680 shares (SEC Form 4)

  4 - Evommune, Inc. (0002044725) (Issuer)
• 66d
  Director Verduyn-Van Weegen Felice Isabel was granted 358,680 shares (SEC Form 4)

  4 - Evommune, Inc. (0002044725) (Issuer)
• 67d
  Director Ra Capital Management, L.P. was granted 35,868 shares (SEC Form 4)

  4 - Evommune, Inc. (0002044725) (Issuer)
• 124d
  Director Hopfner Robert Lorne bought $17,350 worth of shares (1,000 units at $17.35) (SEC Form 4)

  4 - Evommune, Inc. (0002044725) (Issuer)
• 127d
  SEC Form 4 filed by Chief Medical Officer Bauer Eugene

  4 - Evommune, Inc. (0002044725) (Issuer)
• 135d
  President & CEO Pena Luis C. covered exercise/tax liability with 28,138 shares, decreasing direct ownership by 4% to 654,683 units (SEC Form 4)

  4 - Evommune, Inc. (0002044725) (Issuer)
• 135d
  Chief Scientific Officer Patel Jeegar Pravinkumar covered exercise/tax liability with 7,513 shares, decreasing direct ownership by 13% to 49,578 units (SEC Form 4)

  4 - Evommune, Inc. (0002044725) (Issuer)
• 135d
  Chief Business & Legal Officer Moss Gregory S. covered exercise/tax liability with 13,624 shares, decreasing direct ownership by 18% to 60,835 units (SEC Form 4)

  4 - Evommune, Inc. (0002044725) (Issuer)
• 135d
  EVP, Operations Drew Janice Suzann covered exercise/tax liability with 5,074 shares, decreasing direct ownership by 7% to 67,794 units (SEC Form 4)

  4 - Evommune, Inc. (0002044725) (Issuer)
• 135d
  Chief Financial Officer Carver Kyle covered exercise/tax liability with 13,290 shares, decreasing direct ownership by 18% to 62,510 units (SEC Form 4)

  4 - Evommune, Inc. (0002044725) (Issuer)
• 135d
  Chief Medical Officer Bauer Eugene covered exercise/tax liability with 1,478 shares, decreasing direct ownership by 0.54% to 270,818 units (SEC Form 4)

  4 - Evommune, Inc. (0002044725) (Issuer)